Evidence map›Paper›PMID 42193295›Full record

ReviewBiomedicines2026

Seminal Fluid Biomarkers for Early Cancer Detection: A Systematic Review.

Guzel R Sagitova, Anna V Slizova, Andrey O Morozov, Anastasia S Fatyanova, Majid Ebrahimi Warkiani, Andrei V Zvyagin, Alexey S Rzhevskiy

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Biomedicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Guzel R SagitovaInstitute of Molecular Theranostics, Sechenov First Moscow State Medical University, 119991 Moscow, Russia.ORCID 0000-0003-3940-0661
Anna V SlizovaInstitute of Molecular Theranostics, Sechenov First Moscow State Medical University, 119991 Moscow, Russia.ORCID 0009-0005-4398-9052
Andrey O MorozovInstitute for Urology and Reproductive Health, Sechenov University, 119991 Moscow, Russia.ORCID 0000-0001-6694-837X
Anastasia S FatyanovaDepartment of Oncology, Radiotherapy and Reconstructive Surgery, Institution of Clinical Medicine, Sechenov First Moscow State Medical University, 119991 Moscow, Russia.
Majid Ebrahimi WarkianiSchool of Biomedical Engineering, University of Technology Sydney, Sydney, NSW 2007, Australia.
Andrei V ZvyaginResearch Center for Translational Medicine, Sirius University of Science and Technology, 354340 Sochi, Russia.ORCID 0000-0001-8799-2257
Alexey S RzhevskiyInstitute of Molecular Theranostics, Sechenov First Moscow State Medical University, 119991 Moscow, Russia.

Funding

Federal Territory «Sirius» 22-03Russian Science Foundation 24-75-00125
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biomarkerscell-free DNAliquid biopsymetabolomicsmicroRNAprostate cancersementesticular cancer

Identifiers

PMID42193295
PMCPMC13203407

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.